ERC Starting Grant · 2024
Tumour development follows a diversity of complementary biological pathways, including the modification of the tissue structure and vascularization, which are not currently captured by imaging techniques in the clinic. Breast cancer patients undergo a series of imaging sessions using complementary modalities, including ionizing mammographies. In many cases, this imaging is not precise enough for a diagnosis, so that tissue samples in the form of biopsies are used to further characterize the tumour and determine the appropriate treatment. Beyond the pain and stress associated with biopsies, this complex process is costly and time consuming, and delays the time to diagnosis. Ultrasound B-mode…
From the public funding record at EU CORDIS. Describes the funded project, not the reviews below.
← All labs at National Institute of Health and Medical Research (INSERM)